Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is a modified equal-dollar weighted index to objectively identify and select stocks from the Russell 1000® Index in the health care sector that may generate positive alpha relative to traditional passive-style indices through the use of the AlphaDEX® selection methodology. more
| Time Frame | FXH | S&P500 |
|---|---|---|
| 1-Week Return | 0.3% | 1.24% |
| 1-Month Return | 0.62% | 4.94% |
| 3-Month Return | -1.64% | 9.34% |
| 6-Month Return | -3.23% | 9.8% |
| 1-Year Return | 12.31% | 26.99% |
| 3-Year Return | 12.13% | 78.76% |
| 5-Year Return | 0.28% | 79.05% |
| 10-Year Return | 96% | 257.94% |
| Time Frame | FXH | S&P500 |
|---|---|---|
| 1-Week Return | 16.91% | 90.14% |
| 1-Month Return | 7.81% | 79.80% |
| 3-Month Return | -6.49% | 43.64% |
| 6-Month Return | -6.44% | 20.87% |
| 1-Year Return | 12.31% | 26.99% |
| 3-Year Return | 3.89% | 21.36% |
| 5-Year Return | 0.06% | 12.36% |
| 10-Year Return | 6.96% | 13.60% |
| Stock name | Ticker | Weight |
|---|---|---|
Organon & Co. | OGN | 3.83% |
Humana Inc. | HUM | 3.74% |
Elevance Health Inc. | ELV | 2.84% |
DaVita Inc. | DVA | 2.76% |
Solventum Corporation | SOLV | 2.51% |
Exelixis, Inc. | EXEL | 2.47% |
Molina Healthcare, Inc. | MOH | 2.32% |
The Cigna Group | CI | 2.26% |
Incyte Corporation | INCY | 2.21% |
Biogen Inc. | BIIB | 2.21% |
Bio-Rad Laboratories, Inc. (Class A) | BIO | 2.19% |
Globus Medical, Inc. (Class A) | GMED | 2.1% |
Cardinal Health, Inc. | CAH | 2.03% |
Zimmer Biomet Holdings, Inc. | ZBH | 2.01% |
Chemed Corporation | CHE | 2% |
Universal Health Services, Inc. (Class B) | UHS | 1.94% |
Encompass Health Corporation | EHC | 1.84% |
Regeneron Pharmaceuticals, Inc. | REGN | 1.77% |
HCA Healthcare, Inc. | HCA | 1.77% |
Ionis Pharmaceuticals, Inc. | IONS | 1.72% |
Masimo Corporation | MASI | 1.72% |
Penumbra, Inc. | PEN | 1.71% |
Merck & Co., Inc. | MRK | 1.65% |
Amgen Inc. | AMGN | 1.64% |
United Therapeutics Corporation | UTHR | 1.63% |
Tenet Healthcare Corporation | THC | 1.61% |
Becton, Dickinson and Company | BDX | 1.59% |
Pfizer Inc. | PFE | 1.58% |
Illumina, Inc. | ILMN | 1.5% |
QIAGEN N.V. | QGEN | 1.49% |
Revvity, Inc. | RVTY | 1.39% |
Natera, Inc. | NTRA | 1.3% |
Henry Schein, Inc. | HSIC | 1.28% |
Steris Plc | STE | 1.27% |
Quest Diagnostics Incorporated | DGX | 1.27% |
Bristol-Myers Squibb Company | BMY | 1.26% |
Labcorp Holdings Inc. | LH | 1.23% |
UnitedHealth Group Incorporated | UNH | 1.21% |
Gilead Sciences, Inc. | GILD | 1.2% |
ResMed Inc. | RMD | 1.19% |
Certara, Inc. | CERT | 1.16% |
GE HealthCare Technologies Inc. | GEHC | 1.16% |
Medtronic Plc | MDT | 1.16% |
Insmed Incorporated | INSM | 1.14% |
The Cooper Companies, Inc. | COO | 1.13% |
Neurocrine Biosciences, Inc. | NBIX | 1.01% |
Sarepta Therapeutics, Inc. | SRPT | 1% |
Waters Corporation | WAT | 0.98% |
Eli Lilly and Company | LLY | 0.97% |
Halozyme Therapeutics, Inc. | HALO | 0.91% |
Agilent Technologies, Inc. | A | 0.86% |
IQVIA Holdings Inc. | IQV | 0.84% |
BioMarin Pharmaceutical Inc. | BMRN | 0.82% |
Align Technology, Inc. | ALGN | 0.81% |
Johnson & Johnson | JNJ | 0.81% |
Thermo Fisher Scientific Inc. | TMO | 0.78% |
Medpace Holdings, Inc. | MEDP | 0.77% |
Abbott Laboratories | ABT | 0.73% |
Medline Inc. (Class A) | MDLN | 0.71% |
Zoetis Inc. | ZTS | 0.58% |
West Pharmaceutical Services, Inc. | WST | 0.51% |
DexCom, Inc. | DXCM | 0.46% |
Royalty Pharma Plc (Class A) | RPRX | 0.45% |
Sotera Health Company | SHC | 0.44% |
Edwards Lifesciences Corporation | EW | 0.42% |
AbbVie Inc. | ABBV | 0.4% |
IDEXX Laboratories, Inc. | IDXX | 0.39% |
Vertex Pharmaceuticals Incorporated | VRTX | 0.39% |
Intuitive Surgical, Inc. | ISRG | 0.38% |
Stryker Corporation | SYK | 0.38% |
Viking Therapeutics, Inc. | VKTX | 0.38% |
Envista Holdings Corporation | NVST | 0.37% |
Danaher Corporation | DHR | 0.37% |
Boston Scientific Corporation | BSX | 0.36% |
Alnylam Pharmaceuticals, Inc. | ALNY | 0.36% |
Veeva Systems Inc. (Class A) | VEEV | 0.36% |
US Dollar | .USD | 0.08% |
| Sector | Weight |
|---|---|
|
Health care | 100.00% |
First Trust Health Care AlphaDEX® Fund (FXH) share price today is $114.3021.
Yes, Indians can buy shares of First Trust Health Care AlphaDEX® Fund (FXH) on Vested. To buy FXH from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of First Trust Health Care AlphaDEX® Fund (FXH) on Vested. You can start investing in First Trust Health Care AlphaDEX® Fund (FXH) with a minimum investment of $1.
The 52-week high price of First Trust Health Care AlphaDEX® Fund (FXH) is $120.13. The 52-week low price of First Trust Health Care AlphaDEX® Fund (FXH) is $96.71.
The stock symbol (or ticker) of First Trust Health Care AlphaDEX® Fund is FXH.
Yes, you can setup SIP in First Trust Health Care AlphaDEX® Fund shares. Follow the below steps to create the SIP:
Here is the historical performance of FXH on the Vested app.
The expense ratio of First Trust Health Care AlphaDEX® Fund (FXH) is 0.62%.
Link copied